EventsCliniciansPacientsResearchersATMPsCell therapyGen TherapyBusiness ModelDrug DiscoveryEconomicsInvestmentMarketaccessRegulationResearchCTGCTGregor Cuzak 12 September 2024 Event Date: 6 September 2024 • 09:00 do: 6 September 2024 • European Commission Hosts Sixth Regional HTA Event in Budapest The European Commission recently held its sixth regional event in Budapest, focusing on the upcoming Health Technology Assessment (HTA) regulation. Set to launch in January 2025, this new framework aims to streamline the evaluation ... More
EventsCliniciansResearchersCell therapyGen TherapyGMPClinic studyMarketaccessRegulationResearchCharite BerlinCTGCTNICUMCUtrechtGregor Cuzak 1 July 2024 Panel Discussion on ATMP Regulation The CTGCT organised its first Panel Discussion on 29 May entitled: ATMP Regulation. The main takeaway from the very successful session was that the strong potential of the Slovenian ecosystem requires the will to ... More
ArticlesCliniciansPacientsResearchersDrug DiscoveryMarketaccessRegulationResearchCTGCTGregor Cuzak 27 June 2024 Bespoke Gene Therapy Consortium – cooperation for rare disease therapies At the Bespoke Gene Therapy Consortium (BGTC, website), a consortium for the treatment of rare monogenetic diseases, they aim to treat neglected diseases with a very small number of patients with a focus solely ... More
EventsCliniciansPacientsResearchersGen TherapyGMPClinic studyDatamanagementDrug DiscoveryEthicalcommitteeInvestmentLaboratoryLogisticsManufacturing ProcessModalitetadelovanjazdravilaPharmacodynamicsPharmacokineticsPre ClinicalRaw MaterialRegulationResearchCTGCTNICGregor Cuzak 26 June 2024 Event Date: 14 June 2024 • 09:00 − 17:00 CTNNB1 Conference – One Year to Cure One year to cure is the goal shared by parents of children with the CTNNB1 Syndrome rare disease. Out of approximately 400 known cases worldwide, 82 families with children gathered at the conference in ... More